The global market for Asthma Drugs was valued at US$ 237 million in the year 2024 and is projected to reach a revised size of US$ 317 million by 2031, growing at a CAGR of 4.3% during the forecast period.

Asthma Drugs Market

Asthma is a disease that affects the lungs and is characterized by wheezing, coughing, breathlessness, and chest tightness. It is a chronic ailment of the respiratory tract, which is caused by the obstruction of the flow of air and bronchospasms, where the muscles around the respiratory tract swell up. The disease is believed to be caused by genetic as well as environmental factors.

The American Academy of Allergy Asthma and Immunology classifies asthma under four categories: exercise-induced asthma, allergic asthma, occupational asthma, and childhood asthma. The Asthma and Allergy Foundation of America classifies asthma into two categories: allergic asthma and non-allergic asthma. It is an incurable disease but can be controlled with the help of diagnosis at the right time, followed by regular therapy.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Asthma Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Asthma Drugs.

The Asthma Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Asthma Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Asthma Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Asthma Drugs Market Report

Report Metric	Details
Report Name	Asthma Drugs Market
Accounted market size in year	US$ 237 million
Forecasted market size in 2031	US$ 317 million
CAGR	4.3%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Quick-relief Medications (Rescue Medications) Medications for Allergy-induced Asthma
Segment by Application	Allergic Asthma Non-Allergic Asthma
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Pfizer, GlaxoSmithKline, Novartis, Merck, Boehringer Ingelheim, AstraZeneca, Roche, Teva Pharmaceutical, Vectura Group
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Asthma Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Asthma Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Asthma Drugs Market growing?

Ans: The Asthma Drugs Market witnessing a CAGR of 4.3% during the forecast period 2025-2031.

What is the Asthma Drugs Market size in 2031?

Ans: The Asthma Drugs Market size in 2031 will be US$ 317 million.

Who are the main players in the Asthma Drugs Market report?

Ans: The main players in the Asthma Drugs Market are Pfizer, GlaxoSmithKline, Novartis, Merck, Boehringer Ingelheim, AstraZeneca, Roche, Teva Pharmaceutical, Vectura Group

What are the Application segmentation covered in the Asthma Drugs Market report?

Ans: The Applications covered in the Asthma Drugs Market report are Allergic Asthma, Non-Allergic Asthma

What are the Type segmentation covered in the Asthma Drugs Market report?

Ans: The Types covered in the Asthma Drugs Market report are Quick-relief Medications (Rescue Medications), Medications for Allergy-induced Asthma

1 Asthma Drugs Market Overview

1.1 Product Definition

1.2 Asthma Drugs by Type

1.2.1 Global Asthma Drugs Market Value Comparison by Type (2024 VS 2031)

1.2.2 Quick-relief Medications (Rescue Medications)

1.2.3 Medications for Allergy-induced Asthma

1.3 Asthma Drugs by Application

1.3.1 Global Asthma Drugs Market Value by Application (2024 VS 2031)

1.3.2 Allergic Asthma

1.3.3 Non-Allergic Asthma

1.4 Global Asthma Drugs Market Size Estimates and Forecasts

1.4.1 Global Asthma Drugs Revenue 2020-2031

1.4.2 Global Asthma Drugs Sales 2020-2031

1.4.3 Global Asthma Drugs Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Asthma Drugs Market Competition by Manufacturers

2.1 Global Asthma Drugs Sales Market Share by Manufacturers (2020-2025)

2.2 Global Asthma Drugs Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Asthma Drugs Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Asthma Drugs, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Asthma Drugs, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Asthma Drugs, Product Type & Application

2.7 Global Key Manufacturers of Asthma Drugs, Date of Enter into This Industry

2.8 Global Asthma Drugs Market Competitive Situation and Trends

2.8.1 Global Asthma Drugs Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Asthma Drugs Players Market Share by Revenue

2.8.3 Global Asthma Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Asthma Drugs Market Scenario by Region

3.1 Global Asthma Drugs Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Asthma Drugs Sales by Region: 2020-2031

3.2.1 Global Asthma Drugs Sales by Region: 2020-2025

3.2.2 Global Asthma Drugs Sales by Region: 2026-2031

3.3 Global Asthma Drugs Revenue by Region: 2020-2031

3.3.1 Global Asthma Drugs Revenue by Region: 2020-2025

3.3.2 Global Asthma Drugs Revenue by Region: 2026-2031

3.4 North America Asthma Drugs Market Facts & Figures by Country

3.4.1 North America Asthma Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Asthma Drugs Sales by Country (2020-2031)

3.4.3 North America Asthma Drugs Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Asthma Drugs Market Facts & Figures by Country

3.5.1 Europe Asthma Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Asthma Drugs Sales by Country (2020-2031)

3.5.3 Europe Asthma Drugs Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Asthma Drugs Market Facts & Figures by Region

3.6.1 Asia Pacific Asthma Drugs Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Asthma Drugs Sales by Region (2020-2031)

3.6.3 Asia Pacific Asthma Drugs Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Asthma Drugs Market Facts & Figures by Country

3.7.1 Latin America Asthma Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Asthma Drugs Sales by Country (2020-2031)

3.7.3 Latin America Asthma Drugs Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Asthma Drugs Market Facts & Figures by Country

3.8.1 Middle East and Africa Asthma Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Asthma Drugs Sales by Country (2020-2031)

3.8.3 Middle East and Africa Asthma Drugs Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Asthma Drugs Sales by Type (2020-2031)

4.1.1 Global Asthma Drugs Sales by Type (2020-2025)

4.1.2 Global Asthma Drugs Sales by Type (2026-2031)

4.1.3 Global Asthma Drugs Sales Market Share by Type (2020-2031)

4.2 Global Asthma Drugs Revenue by Type (2020-2031)

4.2.1 Global Asthma Drugs Revenue by Type (2020-2025)

4.2.2 Global Asthma Drugs Revenue by Type (2026-2031)

4.2.3 Global Asthma Drugs Revenue Market Share by Type (2020-2031)

4.3 Global Asthma Drugs Price by Type (2020-2031)

5 Segment by Application

5.1 Global Asthma Drugs Sales by Application (2020-2031)

5.1.1 Global Asthma Drugs Sales by Application (2020-2025)

5.1.2 Global Asthma Drugs Sales by Application (2026-2031)

5.1.3 Global Asthma Drugs Sales Market Share by Application (2020-2031)

5.2 Global Asthma Drugs Revenue by Application (2020-2031)

5.2.1 Global Asthma Drugs Revenue by Application (2020-2025)

5.2.2 Global Asthma Drugs Revenue by Application (2026-2031)

5.2.3 Global Asthma Drugs Revenue Market Share by Application (2020-2031)

5.3 Global Asthma Drugs Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Pfizer

6.1.1 Pfizer Company Information

6.1.2 Pfizer Description and Business Overview

6.1.3 Pfizer Asthma Drugs Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Pfizer Asthma Drugs Product Portfolio

6.1.5 Pfizer Recent Developments/Updates

6.2 GlaxoSmithKline

6.2.1 GlaxoSmithKline Company Information

6.2.2 GlaxoSmithKline Description and Business Overview

6.2.3 GlaxoSmithKline Asthma Drugs Sales, Revenue and Gross Margin (2020-2025)

6.2.4 GlaxoSmithKline Asthma Drugs Product Portfolio

6.2.5 GlaxoSmithKline Recent Developments/Updates

6.3 Novartis

6.3.1 Novartis Company Information

6.3.2 Novartis Description and Business Overview

6.3.3 Novartis Asthma Drugs Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Novartis Asthma Drugs Product Portfolio

6.3.5 Novartis Recent Developments/Updates

6.4 Merck

6.4.1 Merck Company Information

6.4.2 Merck Description and Business Overview

6.4.3 Merck Asthma Drugs Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Merck Asthma Drugs Product Portfolio

6.4.5 Merck Recent Developments/Updates

6.5 Boehringer Ingelheim

6.5.1 Boehringer Ingelheim Company Information

6.5.2 Boehringer Ingelheim Description and Business Overview

6.5.3 Boehringer Ingelheim Asthma Drugs Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Boehringer Ingelheim Asthma Drugs Product Portfolio

6.5.5 Boehringer Ingelheim Recent Developments/Updates

6.6 AstraZeneca

6.6.1 AstraZeneca Company Information

6.6.2 AstraZeneca Description and Business Overview

6.6.3 AstraZeneca Asthma Drugs Sales, Revenue and Gross Margin (2020-2025)

6.6.4 AstraZeneca Asthma Drugs Product Portfolio

6.6.5 AstraZeneca Recent Developments/Updates

6.7 Roche

6.7.1 Roche Company Information

6.7.2 Roche Description and Business Overview

6.7.3 Roche Asthma Drugs Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Roche Asthma Drugs Product Portfolio

6.7.5 Roche Recent Developments/Updates

6.8 Teva Pharmaceutical

6.8.1 Teva Pharmaceutical Company Information

6.8.2 Teva Pharmaceutical Description and Business Overview

6.8.3 Teva Pharmaceutical Asthma Drugs Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Teva Pharmaceutical Asthma Drugs Product Portfolio

6.8.5 Teva Pharmaceutical Recent Developments/Updates

6.9 Vectura Group

6.9.1 Vectura Group Company Information

6.9.2 Vectura Group Description and Business Overview

6.9.3 Vectura Group Asthma Drugs Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Vectura Group Asthma Drugs Product Portfolio

6.9.5 Vectura Group Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Asthma Drugs Industry Chain Analysis

7.2 Asthma Drugs Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Asthma Drugs Production Mode & Process Analysis

7.4 Asthma Drugs Sales and Marketing

7.4.1 Asthma Drugs Sales Channels

7.4.2 Asthma Drugs Distributors

7.5 Asthma Drugs Customer Analysis

8 Asthma Drugs Market Dynamics

8.1 Asthma Drugs Industry Trends

8.2 Asthma Drugs Market Drivers

8.3 Asthma Drugs Market Challenges

8.4 Asthma Drugs Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Asthma Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Asthma Drugs Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Asthma Drugs Market Competitive Situation by Manufacturers in 2024

Table 4. Global Asthma Drugs Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Asthma Drugs Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Asthma Drugs Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Asthma Drugs Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Asthma Drugs Average Price (USD/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Asthma Drugs, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Asthma Drugs, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Asthma Drugs, Product Type & Application

Table 12. Global Key Manufacturers of Asthma Drugs, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Asthma Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Asthma Drugs as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Asthma Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Asthma Drugs Sales by Region (2020-2025) & (K Units)

Table 18. Global Asthma Drugs Sales Market Share by Region (2020-2025)

Table 19. Global Asthma Drugs Sales by Region (2026-2031) & (K Units)

Table 20. Global Asthma Drugs Sales Market Share by Region (2026-2031)

Table 21. Global Asthma Drugs Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Asthma Drugs Revenue Market Share by Region (2020-2025)

Table 23. Global Asthma Drugs Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Asthma Drugs Revenue Market Share by Region (2026-2031)

Table 25. North America Asthma Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Asthma Drugs Sales by Country (2020-2025) & (K Units)

Table 27. North America Asthma Drugs Sales by Country (2026-2031) & (K Units)

Table 28. North America Asthma Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Asthma Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Asthma Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Asthma Drugs Sales by Country (2020-2025) & (K Units)

Table 32. Europe Asthma Drugs Sales by Country (2026-2031) & (K Units)

Table 33. Europe Asthma Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Asthma Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Asthma Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Asthma Drugs Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Asthma Drugs Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Asthma Drugs Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Asthma Drugs Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Asthma Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Asthma Drugs Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Asthma Drugs Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Asthma Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Asthma Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Asthma Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Asthma Drugs Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Asthma Drugs Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Asthma Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Asthma Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Asthma Drugs Sales (K Units) by Type (2020-2025)

Table 51. Global Asthma Drugs Sales (K Units) by Type (2026-2031)

Table 52. Global Asthma Drugs Sales Market Share by Type (2020-2025)

Table 53. Global Asthma Drugs Sales Market Share by Type (2026-2031)

Table 54. Global Asthma Drugs Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Asthma Drugs Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Asthma Drugs Revenue Market Share by Type (2020-2025)

Table 57. Global Asthma Drugs Revenue Market Share by Type (2026-2031)

Table 58. Global Asthma Drugs Price (USD/Unit) by Type (2020-2025)

Table 59. Global Asthma Drugs Price (USD/Unit) by Type (2026-2031)

Table 60. Global Asthma Drugs Sales (K Units) by Application (2020-2025)

Table 61. Global Asthma Drugs Sales (K Units) by Application (2026-2031)

Table 62. Global Asthma Drugs Sales Market Share by Application (2020-2025)

Table 63. Global Asthma Drugs Sales Market Share by Application (2026-2031)

Table 64. Global Asthma Drugs Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Asthma Drugs Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Asthma Drugs Revenue Market Share by Application (2020-2025)

Table 67. Global Asthma Drugs Revenue Market Share by Application (2026-2031)

Table 68. Global Asthma Drugs Price (USD/Unit) by Application (2020-2025)

Table 69. Global Asthma Drugs Price (USD/Unit) by Application (2026-2031)

Table 70. Pfizer Company Information

Table 71. Pfizer Description and Business Overview

Table 72. Pfizer Asthma Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 73. Pfizer Asthma Drugs Product

Table 74. Pfizer Recent Developments/Updates

Table 75. GlaxoSmithKline Company Information

Table 76. GlaxoSmithKline Description and Business Overview

Table 77. GlaxoSmithKline Asthma Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 78. GlaxoSmithKline Asthma Drugs Product

Table 79. GlaxoSmithKline Recent Developments/Updates

Table 80. Novartis Company Information

Table 81. Novartis Description and Business Overview

Table 82. Novartis Asthma Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 83. Novartis Asthma Drugs Product

Table 84. Novartis Recent Developments/Updates

Table 85. Merck Company Information

Table 86. Merck Description and Business Overview

Table 87. Merck Asthma Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 88. Merck Asthma Drugs Product

Table 89. Merck Recent Developments/Updates

Table 90. Boehringer Ingelheim Company Information

Table 91. Boehringer Ingelheim Description and Business Overview

Table 92. Boehringer Ingelheim Asthma Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 93. Boehringer Ingelheim Asthma Drugs Product

Table 94. Boehringer Ingelheim Recent Developments/Updates

Table 95. AstraZeneca Company Information

Table 96. AstraZeneca Description and Business Overview

Table 97. AstraZeneca Asthma Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 98. AstraZeneca Asthma Drugs Product

Table 99. AstraZeneca Recent Developments/Updates

Table 100. Roche Company Information

Table 101. Roche Description and Business Overview

Table 102. Roche Asthma Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 103. Roche Asthma Drugs Product

Table 104. Roche Recent Developments/Updates

Table 105. Teva Pharmaceutical Company Information

Table 106. Teva Pharmaceutical Description and Business Overview

Table 107. Teva Pharmaceutical Asthma Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 108. Teva Pharmaceutical Asthma Drugs Product

Table 109. Teva Pharmaceutical Recent Developments/Updates

Table 110. Vectura Group Company Information

Table 111. Vectura Group Description and Business Overview

Table 112. Vectura Group Asthma Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 113. Vectura Group Asthma Drugs Product

Table 114. Vectura Group Recent Developments/Updates

Table 115. Key Raw Materials Lists

Table 116. Raw Materials Key Suppliers Lists

Table 117. Asthma Drugs Distributors List

Table 118. Asthma Drugs Customers List

Table 119. Asthma Drugs Market Trends

Table 120. Asthma Drugs Market Drivers

Table 121. Asthma Drugs Market Challenges

Table 122. Asthma Drugs Market Restraints

Table 123. Research Programs/Design for This Report

Table 124. Key Data Information from Secondary Sources

Table 125. Key Data Information from Primary Sources

Table 126. Authors List of This Report

List of Figures

Figure 1. Product Picture of Asthma Drugs

Figure 2. Global Asthma Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Asthma Drugs Market Share by Type: 2024 & 2031

Figure 4. Quick-relief Medications (Rescue Medications) Product Picture

Figure 5. Medications for Allergy-induced Asthma Product Picture

Figure 6. Global Asthma Drugs Market Value by Application (2020-2031) & (US$ Million)

Figure 7. Global Asthma Drugs Market Share by Application: 2024 & 2031

Figure 8. Allergic Asthma

Figure 9. Non-Allergic Asthma

Figure 10. Global Asthma Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 11. Global Asthma Drugs Market Size (2020-2031) & (US$ Million)

Figure 12. Global Asthma Drugs Sales (2020-2031) & (K Units)

Figure 13. Global Asthma Drugs Average Price (USD/Unit) & (2020-2031)

Figure 14. Asthma Drugs Report Years Considered

Figure 15. Asthma Drugs Sales Share by Manufacturers in 2024

Figure 16. Global Asthma Drugs Revenue Share by Manufacturers in 2024

Figure 17. Global 5 and 10 Largest Asthma Drugs Players: Market Share by Revenue in Asthma Drugs in 2024

Figure 18. Asthma Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 19. Global Asthma Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 20. North America Asthma Drugs Sales Market Share by Country (2020-2031)

Figure 21. North America Asthma Drugs Revenue Market Share by Country (2020-2031)

Figure 22. U.S. Asthma Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 23. Canada Asthma Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 24. Europe Asthma Drugs Sales Market Share by Country (2020-2031)

Figure 25. Europe Asthma Drugs Revenue Market Share by Country (2020-2031)

Figure 26. Germany Asthma Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 27. France Asthma Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. U.K. Asthma Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. Italy Asthma Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. Russia Asthma Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Asia Pacific Asthma Drugs Sales Market Share by Region (2020-2031)

Figure 32. Asia Pacific Asthma Drugs Revenue Market Share by Region (2020-2031)

Figure 33. China Asthma Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Japan Asthma Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. South Korea Asthma Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. India Asthma Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. Australia Asthma Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. Taiwan Asthma Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Indonesia Asthma Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Thailand Asthma Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Malaysia Asthma Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Philippines Asthma Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Latin America Asthma Drugs Sales Market Share by Country (2020-2031)

Figure 44. Latin America Asthma Drugs Revenue Market Share by Country (2020-2031)

Figure 45. Mexico Asthma Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Brazil Asthma Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Argentina Asthma Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Middle East and Africa Asthma Drugs Sales Market Share by Country (2020-2031)

Figure 49. Middle East and Africa Asthma Drugs Revenue Market Share by Country (2020-2031)

Figure 50. Turkey Asthma Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Saudi Arabia Asthma Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. U.A.E Asthma Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Global Sales Market Share of Asthma Drugs by Type (2020-2031)

Figure 54. Global Revenue Market Share of Asthma Drugs by Type (2020-2031)

Figure 55. Global Asthma Drugs Price (USD/Unit) by Type (2020-2031)

Figure 56. Global Sales Market Share of Asthma Drugs by Application (2020-2031)

Figure 57. Global Revenue Market Share of Asthma Drugs by Application (2020-2031)

Figure 58. Global Asthma Drugs Price (USD/Unit) by Application (2020-2031)

Figure 59. Asthma Drugs Value Chain

Figure 60. Channels of Distribution (Direct Vs Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-29F16707

Wed Nov 12 00:00:00 UTC 2025

Add to Cart

Global Asthma Attack Alert System Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages

Type: Report

Code: QYRE-Auto-19R17068

Wed Nov 12 00:00:00 UTC 2025

Add to Cart

Global Heated Humidified High-Flow Therapy Systems Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages

Type: Report

Code: QYRE-Auto-20V17068

Tue Nov 11 00:00:00 UTC 2025

Add to Cart

Global Computer-based Spirometer Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages

Type: Report

Code: QYRE-Auto-36W16800

Mon Nov 10 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Asthma Drugs Market Research Report 2025

Published Date: August 2025

Report Code: QYRE-Auto-37N9640

Global Asthma Drugs Market Research Report 2025

FEATURED COMPANIES

Asthma Drugs Market Size

Asthma Drugs Market

Report Scope

Scope of Asthma Drugs Market Report

Core Chapters

FAQ for this report

How fast is Asthma Drugs Market growing?

What is the Asthma Drugs Market size in 2031?

Who are the main players in the Asthma Drugs Market report?

What are the Application segmentation covered in the Asthma Drugs Market report?

What are the Type segmentation covered in the Asthma Drugs Market report?

FEATURED COMPANIES

RELATED REPORTS